Lawmakers are going to have a difficult time with this one as they are not technically up to date enough as a whole to comprehend how all of this works in my estimation. with understanding the algorithms of finance and the economy, Wall Street showed us that. Sad, but it is true and this...
Posted to
The Medical Quack .... by Barbara Duck
on 11-28-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, healthcare, privacy, health insurance, Prescriptions, Congress, Hospitals, Blue Cross, Blue Shield, Venture Capital, Reserve Funds, Profits
This brings about a good question when it comes to paying commissions on selling health insurance, why do we need to pay this and not have some additional revenues paid here go towards claims? The reason I say this is so many of the health insurance brokers are just web sites that bring many carriers...
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
Where does the greed lie perhaps might be the question. Today it takes a lot of money to create a new drug and as we have seen from the new approach from the FDA, more information and documentation is required. Investors want a return on some of the biotech research that has not quite matured yet...
Posted to
The Medical Quack .... by Barbara Duck
on 10-26-2008
Filed under: Medically Related, Insurance, My Commentaries, healthcare, health insurance, Physicians, HMO, Hospitals, Fraud, NIH, Whistle Blower, Beware of Geeks Bearing Formulas, Greed
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
on 10-13-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
The Human audit trail has arrived or I should say will arrive in January. Will we someday all be walking around with a device like this clipped to our clothing? This looks like an item that could be integrated in to one of the online Personal Healthcare Records programs as a next step . ...
Posted to
The Medical Quack .... by Barbara Duck
on 10-12-2008
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, My Commentaries, healthcare, Medical Records, health insurance, PHR, Google Health, HealthVault, software, fitness monitoring, Fitness, Big Brother, Employer health InsuranceInsurance
Medical Quack on Reuters. Now this is a sad state of affairs to be the prudent consumer, and yet you are potentially taking money out of your doctor's pocket by doing so when it comes to pay for performance for them, so what's up with this when purchasing $4.00 Generic Drugs. BD...
Posted to
The Medical Quack .... by Barbara Duck
on 09-18-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, My Commentaries, health insurance, Physicians, Pharma, HMO, Generic Drugs, Pay for Performance, Patients